Genedata AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genedata AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10886
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Basel, Switzerland.

Genedata AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genedata AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
Licensing Agreements 14
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata AG – Key Competitors 20
Genedata AG – Key Employees 21
Genedata AG – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Strategy And Business Planning 23
Feb 21, 2017: Genedata Expands Into United Kingdom 23
Financial Announcements 24
Aug 20, 2018: Aptevo Therapeutics deploys Genedata Biologics to streamline Cancer Immunotherapy R&D 24
Government and Public Interest 25
Jul 10, 2018: MyBio Adopts Genedata for Improving Antibiotic Production Processes 25
Product News 26
Jun 06, 2017: Genedata Announces New Solution for Efficient Analysis of High-Throughput Automated Patch Clamp Experiments 26
Feb 02, 2018: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer 27
Jan 31, 2018: Genedata Announces Genedata Screener for Massive Mechanistic Analysis 28
Other Significant Developments 29
Oct 02, 2018: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors 29
Feb 27, 2018: Sanofi Adopts Genedata Selector to Optimize Strain Development 30
Jan 11, 2018: Genedata Announces New Solution for CRISPR Data Management and Analysis 31
Dec 20, 2017: Genedata Profiler Moves to High-Performance Clouds 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Genedata AG, Pharmaceuticals & Healthcare, Key Facts 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata AG, Key Competitors 20
Genedata AG, Key Employees 21
Genedata AG, Subsidiaries 22

List of Figures
Genedata AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genedata AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genedata AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hainan Pharmaceutical Co., Ltd. (000566):企業概要、財務及び戦略的SWOT分析
    Summary Hainan Pharmaceutical Co., Ltd. (Hainan) is a pharmaceutical company. The company develops, manufactures and sells antineoplastic, gastrointestinal drugs, antibiotic drugs and antiviral drugs. Hainan's products include Paclitaxel Injection, anti-cancer drug, Fengliao Changweikang granules, M …
  • Endocyte, Inc. (ECYT):企業の財務及び戦略的SWOT分析
    Summary Endocyte, Inc. (Endocyte) is a biopharmaceutical company that focuses on finding new treatments for cancer that pair small molecule drug conjugates with companion imaging agents. The company’s pipeline products include EC1456, EC1788 are used to treat Solid Tumors; EC0652 to treat Prostate T …
  • Pfizer Inc (PFE):企業のM&A・提携動向(医療機器分野)
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respiratory, cardiovascular and metabolic d …
  • Capsalus Corp. (WELL)(製薬・医療分野):企業M&A動向
    Summary Capsalus Corp. (Capsalus) is a wellness solution company. The company provides nutritional products and healthcare services. It provides services to start-up companies with operating infrastructure, financial support and strategic path to enterprises promoting health, wellness and prosperity …
  • TaiwanJ Pharmaceuticals Co Ltd (6549):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiwanJ Pharmaceuticals Co Ltd (TaiwanJ) is a pharmaceutical company that develops and commercialize small molecules for unmet medical needs such as chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It develops TLR4, a transmembrane protein that provides key medi …
  • Eros International plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Eros International plc Mergers …
  • Energy Focus, Inc. (EFOI)-エネルギー分野:企業M&A・提携分析
    Summary Energy Focus, Inc. (Energy Focus) is a provider of energy efficient LED lighting products and technologies. The company, together with its subsidiaries, designs, develops, manufactures, markets, and installs energy-efficient lighting systems and solutions. Its military maritime products incl …
  • Arab Petroleum Investments Corporation:企業のM&A・提携動向(石油・ガス分野)
    Summary Arab Petroleum Investments Corporation (APICORP) is a multilateral banking institution which provides various finance solutions to the energy industry. The company provides tailored solutions to the complex and challenging financing needs of large projects. Its activities include making dire …
  • Youngbo Chemical Co., Ltd. (014440):企業概要、財務及び戦略的SWOT分析
    Summary Youngbo Chemical Co., Ltd. (Youngbo Chemical) is a chemical manufacturer. The company manufactures and distributes cross-linked polyolefin foam for various industrial and manufacturing industries. Its products include polyolefin foam products such as artilon, epilon, heatlon, filmy, young bo …
  • Eurasian Natural Resources PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Eurasian Natural Resources PLC …
  • Millar Instruments, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Millar Instruments, Inc. Merger …
  • Bhansali Engineering Polymers Limited (BEPL):企業財務及び戦略的SWOT分析
    Summary Bhansali Engineering Polymers Limited (BEPL) is a petrochemical company that manufactures and markets acrylonitrile butadiene styrene. The company offers products which include general ABS, ABS-GF or SAN-GF, extrusion ABS, flame retardant ABS, PC or ABS alloys, PMMA-ABS, PVC modifier, SAN re …
  • MModal IP LLC.:企業の戦略的SWOT分析
    MModal IP LLC. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Veresen Inc. (VSN):企業のM&A・提携動向(石油・ガス分野)
    Summary Veresen Inc. (Veresen) is an oil and gas company that offers energy infrastructure services. The company provides services in the areas of pipelines, midstream and power. Its pipeline business comprises of interests in two pipeline systems which include the Alliance Pipeline and Alberta Etha …
  • Xizang Haisco Pharmaceutical Group Co Ltd (002653):企業のM&A・提携動向(医療分野)
    Summary Xizang Haisco Pharmaceutical Group Co Ltd (Haisco Pharma) is a pharmaceutical company that researches and develops new therapeutics in the areas of parenteral nutrition, anti-infectious and hepatobiliary diseases. Its product portfolio comprise injection for trace elements, compound vitamin, …
  • Fresnillo plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Fresnillo plc Mergers and Acqui …
  • ConceptoMed AS-医療機器分野:企業M&A・提携分析
    Summary ConceptoMed AS (ConceptoMed) is a medical device manufacturer that offers medtech products. The company's products comprise medical syringe and needle, medical tools, Luer-Jack, ConceptoShield, and disposable medical instruments and devices. ConceptoMed also offers epidural injections, plexu …
  • Kawasaki Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Kawasaki Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Uppsala University:企業のM&A・提携動向(医療分野)
    Summary Uppsala University is an educational service provider that offers education and research services. The university offers master programs in the areas of science and technology, arts, law, medicine, languages, social sciences and theology. It conducts pharmaceutical research projects in the a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆